These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 2118527
21. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H. J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [Abstract] [Full Text] [Related]
22. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Yamamoto K, Loskutoff DJ. Am J Pathol; 1997 Sep; 151(3):725-34. PubMed ID: 9284821 [Abstract] [Full Text] [Related]
23. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1. Michel JB, Quertermous T. J Immunol; 1989 Aug 01; 143(3):890-5. PubMed ID: 2501387 [Abstract] [Full Text] [Related]
24. The interaction of plasminogen activator inhibitor 1 with plasminogen activators (tissue-type and urokinase-type) and fibrin: localization of interaction sites and physiologic relevance. Keijer J, Linders M, van Zonneveld AJ, Ehrlich HJ, de Boer JP, Pannekoek H. Blood; 1991 Jul 15; 78(2):401-9. PubMed ID: 1712649 [Abstract] [Full Text] [Related]
25. Circadian variations of plasminogen activator activity, tissue-type plasminogen activator antigen, plasminogen activator inhibition and plasmin inhibition in rat aorta, heart and brain are influenced by endotoxin or aspirin or endotoxin plus aspirin. Kokolis N, Rekkas C, Tsandarliotou M, Smokovitis A. Haemostasis; 1995 Jul 15; 25(3):106-13. PubMed ID: 7607578 [Abstract] [Full Text] [Related]
29. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells. Sakata Y, Okada M, Noro A, Matsuda M. J Biol Chem; 1988 Feb 05; 263(4):1960-9. PubMed ID: 3123483 [Abstract] [Full Text] [Related]
30. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ. Blood; 1988 Nov 05; 72(5):1467-73. PubMed ID: 3140909 [Abstract] [Full Text] [Related]
31. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality. Paloma MJ, Páramo JA, Rocha E. Thromb Haemost; 1995 Dec 05; 74(6):1578-82. PubMed ID: 8772240 [Abstract] [Full Text] [Related]
32. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator. Bartha K, Declerck PJ, Moreau H, Nelles L, Collen D. J Biol Chem; 1991 Jan 15; 266(2):792-7. PubMed ID: 1898737 [Abstract] [Full Text] [Related]
33. Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts. Fukumoto S, Allan EH, Zeheb R, Gelehrter TD, Martin TJ. Endocrinology; 1992 Feb 15; 130(2):797-804. PubMed ID: 1733726 [Abstract] [Full Text] [Related]
34. Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1. Keski-Oja J, Koli K. J Invest Dermatol; 1992 Aug 15; 99(2):193-200. PubMed ID: 1629632 [Abstract] [Full Text] [Related]
35. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2. Gross TJ, Sitrin RG. J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845 [Abstract] [Full Text] [Related]
36. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts. Boxman IL, Quax PH, Löwik CW, Papapoulos SE, Verheijen J, Ponec M. J Invest Dermatol; 1995 Mar 01; 104(3):374-8. PubMed ID: 7861005 [Abstract] [Full Text] [Related]
38. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis. Falkon L, Garí M, Borrell M, Fontcuberta J. Blood Coagul Fibrinolysis; 1992 Feb 01; 3(1):33-8. PubMed ID: 1623118 [Abstract] [Full Text] [Related]
39. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia. Bergonzelli GE, Kruithof EK. J Cell Physiol; 1991 Aug 01; 148(2):306-13. PubMed ID: 1652590 [Abstract] [Full Text] [Related]
40. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. Colucci M, Paramo JA, Collen D. J Clin Invest; 1985 Mar 01; 75(3):818-24. PubMed ID: 3920245 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]